Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Revenue
Operating expenses:    
Research and development 4,462,969 4,573,502
General and administrative 1,878,746 3,211,166
Depreciation expense 11,964 20,920
Total operating expenses 6,353,679 7,805,588
Loss from operations (6,353,679) (7,805,588)
Other income (expense):    
Interest income 30,342
Gain (loss) on change in fair value of derivative liabilities 9,076 (255,995)
Total other income (expense) 39,418 (255,995)
Net loss $ (6,314,261) $ (8,061,583)
Net loss per common share - basic and diluted $ (0.07) $ (0.14)
Weighted average common shares outstanding - basic and diluted 88,434,704 55,892,878